Hormonal Contraceptives Market Set to Surge to $20,672.64 million Globally by 2030, Propelled by a 3.3% CAGR, Unveils Allied Market Research

Introduction:

The global hormonal contraceptives market, valued at $15,026.23 million in 2020, is projected to reach $20,672.64 million by 2030, with a Compound Annual Growth Rate (CAGR) of 3.3% from 2021 to 2030. Hormonal contraceptives leverage hormones like estrogen and progesterone to prevent ovulation and unintended pregnancies, with various forms such as pills, patches, injections, rings, offering a safe and reliable means of birth control.

𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐯𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/4574

Market Dynamics:

The market is expected to witness significant growth due to an increased focus on family planning, addressing health issues associated with teenage pregnancies, and rising awareness about modern contraception methods. However, factors such as the availability of alternative contraceptive methods, health risks, and societal acceptance may pose challenges to market growth.

Market Segmentation:

The global hormonal contraceptives market is segmented by product (oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches), hormone type (progestin-only contraceptive and combined hormonal contraceptive), age group (15-24 years, 25-34 years, 35-44 years, and above 44 years), and end user (hospitals, households, and clinics). Regional analysis covers North America, Europe, Asia-Pacific, and LAMEA.

Covid-19 Impact:

The COVID-19 pandemic had a slightly negative impact on the hormonal contraceptives market due to disruptions in family planning activities. Lockdowns and restrictions led to a decline in the use of hormonal contraception products as reported by the UNFPAs in 2020.

Segment Reviews:

Product Segment: Oral contraceptive pills dominate the market, contributing significantly to revenue in 2020, with vaginal rings projected to experience the fastest growth due to ease of usage and fewer side effects.

Hormone Segment: Combined hormonal contraceptives presently dominate the market and are expected to maintain dominance due to wide availability and higher efficiency.

Age Group Segment: The 15-24 years age group dominates the market and is expected to continue growing due to increased awareness, adoption of emergency contraceptive pills, and concerns about adolescent sexual activity.

End User Segment: The household segment presently dominates the market, attributed to widespread consumption of oral pills to avoid unplanned pregnancies.

Region Segment: North America leads the market, driven by high adoption rates, a well-established healthcare infrastructure, and the presence of key market players.

𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐯𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/4574

Competitive Landscape:

The report provides a comprehensive competitive analysis, profiling key players including the Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc.,

Key Benefits for Stakeholders:

Detailed quantitative analysis of market trends from 2020 to 2030.
Market estimations based on key industry developments.
Comprehensive analysis of the hormonal contraceptives market by product, hormone type, age group, end user, and region.
In-depth regional analysis to aid strategic business planning.
Enlistment of development strategies by key manufacturers for a better understanding of the competitive scenario.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

𝐇𝐚𝐯𝐞 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬? 𝐂𝐨𝐧𝐬𝐮𝐥𝐭 𝐰𝐢𝐭𝐡 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/connect-to-analyst/4574

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.